Bladder cancer: open trials in Australia

34 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Trial Treatment · Phase 1 · Eli Lilly and Company
St Vincent's Hospital, Darlinghurst · Calvary Mater Newcastle, Hunter Region, NSW · GenesisCare - North Shore, St Leonards · Macquarie University, Sydney
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
St Vincent's Hospital, Darlinghurst · Linear Clinical Research, Nedlands
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
NSW Health - Blacktown Hospital, Blacktown · ICON Cancer Centre - Southport, Southport · Macquarie University Hospital - Oncology Department, Sydney
Registry updated 2026-11-04
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Macquarie University ( Site 0031), Macquarie · Mater Hospital Brisbane ( Site 0032), South Brisbane
Registry updated 2026-11-03
NCT07660055
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Darlinghurst
Registry updated 2026-11-03
NCT07475806
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Trial Treatment · Phase 2 · Astellas Pharma Global Development, Inc.
New South Wales · Southport
Registry updated 2026-11-02
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · MacroGenics
ICON Cancer Centre Wesley, Auchenflower · Austin Health- Olivia Newton John Cancer Center, Heidelberg · Icon Cancer Centre Kurralta Park, Kurralta Park
Registry updated 2026-10-28
NCT06995677
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Tyra Biosciences, Inc
Epworth Freemasons-Victoria Parade, Richmond
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Chris O'Brien Lifehouse, Camperdown · Icon Cancer Centre Chermside, Chermside · Monash Medical Centre Clayton, Clayton · Icon Cancer Centre Hobart, Hobart · Icon Cancer Centre Townsville, Hyde Park
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Blacktown Hospital, Blacktown · St Vincent'S Hospital Sydney, Mount Kuring-Gai · GenesisCare -North Shore Oncology, St Leonards · St. John of God Subiaco Hospital, Subiaco · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-10-26
NCT07186842
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Trial Treatment · Phase 1/2 · BioNTech SE
Monash Health, Clayton · Austin Health, Heidelberg
Registry updated 2026-10-15
NCT07671092
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
Trial Treatment · Early phase 1 · RayzeBio, Inc.
Nedlands · Perth · St Leonards
Registry updated 2026-10-13
NCT06960577
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
Trial Treatment · Phase 2 · AstraZeneca
Chermside · Elizabeth Vale · Heidelberg · Hong Kong · Kogarah · Macquarie University · Murdoch · Port Macquarie · St Leonards
Registry updated 2026-10-08
NCT07421700
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Trial Treatment · Phase 1/2 · Pfizer
ICON Cancer Centre Wesley, Auchenflower · Monash Health, Clayton · Macquarie University, North Ryde
Registry updated 2026-10-08
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
Box Hill Hospital, Box Hill · Mater Misericordiae Limited, Brisbane · GenesisCare - Campbelltown, Campbelltown · Austin Health, Heidelberg · Macquarie University, Macquarie University · Sir Charles Gairdner Hospital, Perth · Prince of Wales Hospital, Randwick · Western Health-Sunshine & Footscray Hospitals, St Albans · Calvary Mater Newcastle, Waratah
Registry updated 2026-10-07
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Albury · Birtinya · Brisbane · Saint Leonards · Sydney
Registry updated 2026-10-01
NCT06833073
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Macquarie University ( Site 1801), Macquarie University · Fiona Stanley Hospital ( Site 1803), Perth
Registry updated 2026-10-01
NCT05562830
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 1952), Brisbane
Registry updated 2026-09-28
NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Trial Treatment · Phase 1/2 · Aulos Bioscience, Inc.
Southern Oncology Clinical Research Unit, Bedford Park · Monash Health, Clayton · Peninsula & South Eastern Haematology and Oncology Group, Frankston · Austin Health, Heidelberg · The Alfred Hospital, Melbourne · Southside Cancer Care Centre, Miranda · Sunshine Hospital, Saint Albans
Registry updated 2026-09-18
NCT07341737
SL-28 for Advanced Solid Tumours
Trial Treatment · Phase 1/2 · Second Life Therapeutics
The Southern Oncology Clinical Research Unit (SOCRU), Adelaide · John Flynn Private Hospital, Gold Coast · Liverpool Hospital, Sydney
Registry updated 2026-09-15
NCT07623369
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Huahui Health
Tasman Health Care, Southport · Calvary Mater Newcastle, Waratah
Registry updated 2026-08-21
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Blacktown Hospital, Blacktown · Princess Alexandra Hospital, Brisbane · Liverpool Hospital, Liverpool · Cabrini Hospital - Malvern, Malvern · St Vincent's Hospital, Melbourne · One Clinical Research, Nedlands
Registry updated 2026-08-17
NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · Lumara Bio Oncologics GmbH
Peter MacCallum Cancer Centre, Melbourne · UNSW Sydney, St Vincent's Hospital Sydney, Sydney
Registry updated 2026-08-11
NCT04752722
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Trial Treatment · Phase 1/2 · enGene, Inc.
Gold Coast University Hospital, Southport · Sydney Adventist Hospital, Wahroonga · Icon Cancer Center Windsor Gardens, Windsor Gardens
Registry updated 2026-08-07
NCT06910657
IDOV-Immune for Advanced Solid Tumors
Trial Treatment · Phase 1 · ViroMissile, Inc.
The Alfred Hospital, Melbourne · Westmead Hospital, Westmead
Registry updated 2026-08-05

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error